Skip to main navigation Skip to search Skip to main content

Gastric Cancer Early Detection Using Routine Blood Tests and Artificial Intelligence: Validation Study at Queen Elizabeth Hospital

  • Minji SEO
  • , Ka Man CHEUNG*
  • , Winnie Wing-Yan SUNG
  • , James Chung-Hang CHOW
  • , Harry Ho-Yin YIU
  • , Henry Hin-Wai LIU
  • , Peter Yat-Ming WOO
  • , Ada Sze-Man YIP
  • , Daisy May-Yee KAN
  • , Stephen Ka-Kei NG
  • , Martin SC LEE
  • , Sau-San KAO
  • , David LAM*
  • , Lik To WU
  • *Corresponding author for this work

Research output: Contribution to conferenceConference Paperpeer-review

Abstract

The high mortality of gastric cancer (GC) is largely due to late diagnosis, and a reliable non-invasive detection method is lacking. While existing tumour markers have low sensitivity, routine blood tests (RBTs) like CBC and LRFT can indicate hidden cancer through signs of anaemia, inflammation, and cachexia. The HKUST, HA clinical team (oncology, medicine, surgery, neurosurgery), and HADCL co-developed the RBT-GC model, which can detect GC up to 6 months prior to clinical diagnosis. Previously presented at ASCO 2023 and ESMO GI 2024, this study aims to validate RBT-GC's sensitivity in a hospital setting up to 6 months before the diagnosis date.
Original languageEnglish
Publication statusAccepted/In press - Mar 2025
EventHospital Authority Convention 2025 -
Duration: 1 Mar 20251 Mar 2025

Conference

ConferenceHospital Authority Convention 2025
Period1/03/251/03/25

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Gastric Cancer Early Detection Using Routine Blood Tests and Artificial Intelligence: Validation Study at Queen Elizabeth Hospital'. Together they form a unique fingerprint.

Cite this